The Woman's Hospital of Texas is an HCA Affiliated Hospital established in 1976 by a group of physicians who recognized a need in Houston for a facility focused solely on women in all stages of life.

During the past decade, The Woman's Hospital of Texas conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 13 clinical trials were completed, i.e. on average, 92.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Woman's Hospital of Texas" #1 sponsor was "M.D. Anderson Cancer Center" with 13 trials, followed by "Repros Therapeutics Inc." with 5 trials sponsored, "Bayer" with 4 trials sponsored, "Jaeb Center for Health Research" with 2 trials sponsored and "Lumara Health, Inc." with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Woman's Hospital of Texas" #1 collaborator was "National Cancer Institute (NCI)" with 10 trials as a collaborator, "National Eye Institute (NEI)" with 2 trials as a collaborator, "Pediatric Eye Disease Investigator Group" with 2 trials as a collaborator, "Novartis" with 1 trials as a collaborator and "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "The Woman's Hospital of Texas" are "Uterine Fibroids" (5 trials), "Contraception" (3 trials), "Endometrial Cancer" (3 trials), "Fallopian Tube Serous Adenocarcinoma" (3 trials) and "Postoperative Pain" (3 trials). Many other conditions were trialed in "The Woman's Hospital of Texas" in a lesser frequency.

Most popular intervention types in "The Woman's Hospital of Texas" are "Drug" (33 trials), "Other" (11 trials), "Procedure" (6 trials), "Device" (4 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (7 trials), "Placebo" (6 trials), "Bevacizumab" (3 trials), "Quality-of-Life Assessment" (3 trials) and "Brisdelle (paroxetine mesylate)" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Woman's Hospital of Texas" are 34 trials for "Female" genders and 9 trials for "All" genders.

Currently, there are NaN active trials in "The Woman's Hospital of Texas". undefined are not yet recruiting, 5 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in The Woman's Hospital of Texas, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in The Woman's Hospital of Texas, 1 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".